On the other side, the interaction between lincRNA H19 and miR-21 could be a suitable goal in therapeutic strategies of NSCLC as stated by Zhou and his colleagues especially since they were linked with aggressive cancer stages (Zhou et al. 2017). This evidence concerns the gene H19 and non-small cell lung carcinoma.